Urinary Tract Infection in Patients With Chronic Kidney Disease
Launched by ALEXANDRIA UNIVERSITY · Dec 29, 2022
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
Chronic kidney disease (CKD) patients are at higher risk of urinary tract infections (UTI), as CKD is a state of chronic inflammation, metabolic disturbance and impaired immunocompetence. Moreover, patient with CKD are usually of advanced age and suffer from other comorbidities such as diabetes, hypertension, obesity, and cardiovascular diseases, which also add to their risk of infection.
UTI comprises heterogeneous conditions ranging from mild cystitis, easily treated with oral antibiotics, to life-threatening sepsis and multiple organ failure.
There is scarce information about risk fact...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Males and non-pregnant females aged ≥ 18 years old
- • 2. Patients with CKD stages (G1 to G4)
- • 3. Patients diagnosed with UTI due to urine culture
- Exclusion Criteria:
- • 1. Non-CKD patients
- • 2. pregnant females
- • 3. CKD patients on immunosuppressant agents
- • 4. ESRD patients on hemodialysis
- • 5. Patients with structural abnormalities which make them liable to frequent UTI
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
mohamed mamdouh elsayed, MD
Principal Investigator
Lecturer of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University
Mohammed Abdel Gawad
Study Chair
Nephrology Lecturer, School of Medicine, New Giza University (NGU), Giza, Egypt
Dalia Elzayat
Study Chair
Faculty of Pharmacy, Pharos University, Alexandria, Egypt
Reham Mekawy
Study Chair
Faculty of Pharmacy, Pharos University, Alexandria, Egypt
Salma Mahdy
Study Chair
Faculty of Pharmacy, Pharos University, Alexandria, Egypt
Salma Imam
Study Chair
Faculty of Pharmacy, Pharos University, Alexandria, Egypt
Hala Abo El-hassan
Study Chair
Faculty of Pharmacy, Pharos University, Alexandria, Egypt
Ramy Elwaraky
Study Chair
Department of Clinical Pharmacy, Kidney and Urology Center, Alexandria, Egypt
Engy Emam
Study Chair
Clinical Pharmacist, Alexandria Main University Hospital, Alexandria, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials